HIV Vaccine Production

Project: Research project

Project Details


This contract will provide for the production, scale-up, characterization and formulation of specific vaccine antigens and reagents as directed by the NIAID. In addition pilot lots of candidate vaccines will be produced under GLP/cGMPs appropriate for Phase I and Phase II human clinical trials.
Effective start/end date6/30/997/13/24


  • National Institutes of Health: $224,563.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.